Health and Healthcare Systems

These four questions could save thousands of children from dehydration

A woman with a baby on her back looks on at an informal settlement in the capital Luanda, August 30, 2012. Angolans will go to the polls on Friday to elect lawmakers and their president.

Continuous improvement of diagnostic methods is vital. Image: REUTERS/Siphiwe Sibeko

David Orenstein
Science News Officer, Brown University

A simple new method for assessing dehydration from diarrhea, which kills hundreds of thousands of children each year worldwide, has proven accurate and reliable.

Caregivers in clinics long on patients and short on resources need a quick and accurate way to assess the severity of dehydration. After a study testing it with nearly 500 children in Bangladesh, the four-symptom “DHAKA” score is now the most tested method.

“The DHAKA score now has better evidence for its performance in assessing dehydration in a specifically low-income country setting than any other scale,” says Adam Levine, associate professor of emergency medicine in the Warren Alpert Medical School of Brown University and lead author of the study in The Lancet Global Health. “Looking at it from an evidence-based medicine point of view, it is better than anything else out there.”

In a side-by-side comparison, the study showed that DHAKA, which stands for Dehydration: Assess Kids Accurately, was a significantly better predictor of dehydration severity in children under age five than the current standard, the World Health Organization’s Integrated Management of Childhood Illness (IMCI) guidelines.

Continuous improvement of diagnostic methods is vital, explains Levine, who is also a physician in the Lifespan health system, because in hospitals and clinics where intravenous fluids and beds are in limited supply, it’s imperative that those treatment resources be provided only to severely dehydrated children.

Children with moderate dehydration can be rehydrated orally. Moreover, mistaken overtreatment with IV fluids of only somewhat or non-dehydrated children can result in seizures or difficulty breathing.

 Pneumonia & Diarrhea Deaths, 2015
Image: Bill and Melinda Gates International Vaccine Access Center

The right questions

Levine and colleagues including a team at the International Centre for Diarrhoeal Disease Research in Dhaka, Bangladesh, derived the DHAKA score in 2014 by analyzing the cases of 770 children with diarrhea due to cholera and other serious intestinal infections. The researchers statistically determined which clinical signs at intake best predicted dehydration severity. They found four such symptoms that a nurse or doctor could observe within two minutes to make an accurate diagnosis:

  • General appearance: Is the child restless or irritable, or lethargic or unconscious?
  • Breathing: Is it normal or deep?
  • Skin pinch: After a pinch, does skin snap right back or respond slowly, or very slowly?
  • Tears: Does the child produce a normal volume, less than normal, or none at all?

When applied retrospectively to the patients, the DHAKA score showed significant accuracy, sensitivity, and specificity in identifying which child had no dehydration, moderate dehydration, or severe dehydration. Comparing a child’s weight at intake and after full rehydration makes the definitive measure.

Cholera’s return

In the new study, Levine and his team returned to Dhaka in 2015 to validate the score by testing its predictive value with an entirely new population of 496 patients. This was a crucial step to determine whether the method would work for any group of patients, not just the ones from whom it was derived. Nurses employed both the DHAKA score and IMCI algorithm when new patients arrived.

DHAKA performed well. Each additional point on the 0 to 12 scale predicted a 0.6 percent increase in dehydration and a 1.4-fold increase in the odds of some or severe dehydration. On a statistical measure of accuracy where 0.5 is no better than chance and 1 is perfect, DHAKA rated 0.82 while IMCI rated 0.76.

“Not only is this the first score to be derived and validated in a low-income country setting, but the DHAKA study is also the largest study ever of dehydration assessment of kids anywhere,” Levine says. “If you take the derivation and validation studies together with more than 1,200 children, that’s more than all of the children who have been involved in every other study of every other dehydration scale ever assessed in the developing or the developed world.”

Levine plans one more set of tests that he expects will be necessary before DHAKA can earn the WHO’s endorsement as a new diagnostic standard for use in clinics in resource-limited settings. Next spring, as cholera makes its grim annual return to Bangladesh, he plans to test it in rural clinics where the question will be whether DHAKA is easy enough to use accurately when there isn’t the same degree of training and experience as at the center in Dhaka.

The National Institutes of Health Fogarty International Center funded the research.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Global Health

Share:
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COPD kills more than lung and breast cancer combined. It's time to change that

Nitin Kapoor

November 22, 2024

A historic leap in cancer vaccines – here’s what you need to know

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum